D
P. Heer Kaur, P. W. Davies
Letter
Synlett
Supporting Information
Gade, C. A.; Hashmi, A. S. K. Angew. Chem. Int. Ed. 2013, 52, 5880.
(h) Li, L.; Shu, C.; Zhou, B.; Yu, Y.-F.; Xiao, X.-Y.; Ye, L.-W. Chem.
Sci. 2014, 5, 4057; For reviews, see ref. 7.
Supporting information for this article is available online at
p
p
ortingInformatio
n
Su
p
p
ortingInformatio
n
(9) (a) Dos Santos, M.; Davies, P. W. Chem. Commun. 2014, 50, 6001.
(b) Baker, T.; Davies, P. W. Eur. J. Org. Chem. 2019, 2019, 5201.
(10) Adcock, H. V.; Langer, T.; Davies, P. W. Chem. Eur. J. 2014, 20,
7262.
References and Notes
(11) Hamada, T.; Ye, X.; Stahl, S. S. J. Am. Chem. Soc. 2008, 130, 833.
(12) Cycloisomerisation of Ynamides: General Procedure
AuPicCl2 (5.0 mol%, 5 mol) was added to a 0.2 M solution of
the appropriate ynamide in DCE (0.1 mmol) in a flame-dried
Schlenk tube under argon, and the mixture was heated at 70 °C.
Upon completion of the reaction (TLC), the crude mixture was
passed through a small plug of silica to remove gold residues.
The solvent was then evaporated, and the residue was purified
by column chromatography (hexanes–EtOAc).
(1) (a) Lee, Y.-C.; Kumar, K. Isr. J. Chem. 2018, 58, 531. (b) Quirós, M.
T.; Muñoz, M. P. Top. Heterocycl. Chem. 2016, 46, 117.
(2) (a) Gorin, D. J.; Toste, F. D. Nature 2007, 446, 395. (b) Fürstner,
A.; Davies, P. W. Angew. Chem. Int. Ed. 2007, 46, 3410.
(c) Adcock, H. V.; Davies, P. W. Synthesis 2012, 44, 3401.
(d) Zhang, L. Acc. Chem. Res. 2014, 47, 877. (e) Yeom, H.-S.; Shin,
S. Acc. Chem. Res. 2014, 47, 966. (f) Wang, Y.; Muratore, M. E.;
Echavarren, A. M. Chem. Eur. J. 2015, 21, 7332. (g) Harris, R. J.;
Widenhoefer, R. A. Chem. Soc. Rev. 2016, 45, 4533. (h) Ye, L.-W.;
Zhu, X.-Q.; Sahani, R. L.; Xu, Y.; Qian, P.-C.; Liu, R.-S. Chem. Rev.
2021, in press DOI: 10.1021/acs.chemrev.0c00348. (i) Wang, T.;
Hashmi, A. S. K. Chem. Rev. 2021, in press DOI:
10.1021/acs.chemrev.0c00811.
(3) (a) Pathania, S.; Narang, R. K.; Rawal, R. K. Eur. J. Med. Chem.
2019, 180, 486. (b) Feng, M.; Tang, B.; Liang, S. H.; Jiang, X. Curr.
Top. Med. Chem. 2016, 16, 1200.
(4) For early examples, see: (a) Morita, N.; Krause, N. Angew. Chem.
Int. Ed. 2006, 45, 1897. (b) Nakamura, I.; Sato, T.; Yamamoto, Y.
Angew. Chem. Int. Ed. 2006, 45, 4473. For a review, see:
(c) Debrouwer, W.; Heugebaert, T. S. A.; Roman, B. I.; Stevens, C.
V. Adv. Synth. Catal. 2015, 357, 2975.
1-Allyl-N-benzyl-N-(methylsulfonyl)-1,3-dihydro-2-ben-
zothiophene-1-carboxamide (4b)
Purified by column chromatography [silica gel, hexanes–EtOAc
(7:3)] as a yellow viscous oil; yield: 31 mg (81%). IR (neat): 2925
(w), 1679 (s), 1351 (s), 1162 (s) cm–1 1H NMR (300 MHz,
.
CDCl3): = 2.92 (s, 3 H) overlaps with 3.01–2.95 (m, 1 H), 3.10
(dd, J = 14.2, 7.4 Hz, 1 H), 4.19 (d, J = 14.2 Hz, 1 H), 4.33 (d, J =
16.0 Hz, 1 H), 4.41 (d, J = 14.2 Hz, 1 H), 4.83 (d, J = 16.0 Hz, 1 H),
4.92–5.05 (m, 2 H), 5.46–5.64 (m, 1 H), 7.14–7.31 (m, 9 H). 13C
NMR (101 MHz, CDCl3): = 238.0, 43.3, 47.2, 50.6, 69.0, 120.1,
125.2, 125.3, 127.8, 127.9, 128.4, 128.5, 128.6, 132.2, 135.6,
140.2, 141.0, 175.1. MS (TOF ES+): m/z = 410 (100%) [M + Na]+.
HRMS (TOF ES+): m/z calcd for C20H21NNaO3S2: 410.0861; found:
410.0859.
(5) Davies, P. W.; Albrecht, S. J.-C. Angew. Chem. Int. Ed. 2009, 48,
8372.
(6) (a) Lu, B.; Li, Y.; Wang, Y.; Aue, D. H.; Luo, Y.; Zhang, L. J. Am.
Chem. Soc. 2013, 135, 8512. (b) Shapiro, N. D.; Toste, F. D. J. Am.
Chem. Soc. 2007, 129, 4160. (c) Li, G.; Zhang, L. Angew. Chem. Int.
Ed. 2007, 46, 5156.
N,3-Diallyl-N-(methylsulfonyl)-2-thiaspiro[4.5]decane-3-
carboxamide (9)
Colourless viscous oil; yield: 21.3 mg (60%); IR (neat): 2924 (s),
1
2852 (m), 1681 (s), 1352 (s), 1165 (s) cm–1. H NMR (300 MHz,
CDCl3): = 1.21–1.63 (m, 10 H), overlaps with 1.53 (d, J = 13.6
Hz, 1 H), 2.55 (dd, J = 14.4, 7.2 Hz, 1 H), 2.70 (dd, J = 14.4, 5.8 Hz,
1 H), 2.69 (d, J = 10.7 Hz, 1 H), 2.77 (d, J = 10.7 Hz, 1 H), 2.96 (d,
J = 13.6 Hz, 1 H), 3.28 (s, 3 H), 4.39–4.56 (m, 2 H), 5.05–5.20 (m,
2 H), 5.25–5.42 (m, 2 H), 5.63–5.81 (m, 1 H), 5.86–6.03 (m, 1 H).
13C NMR (101 MHz, CDCl3): = 23.0, 24.0, 26.1, 34.6, 37.8, 43.3,
44.5, 45.8, 46.5, 47.7, 62.3, 119.5, 132.5, 132.8, 174.6. MS (TOF ES+):
m/z = 380 (100%). HRMS (TOF ES+): m/z calcd for C17H27NNaO3S2:
380.1330; found: 380.1338.
(7) (a) Hong, F.-L.; Ye, L.-W. Acc. Chem. Res. 2020, 53, 2003.
(b) Campeau, D.; León Rayo, D. F.; Mansour, A.; Muratov, K.;
Gagosz, F. Chem. Rev. 2021, in press DOI: 10.1021/acs.chem-
rev.0c00788. (c) Evano, G.; Lecomte, M.; Thilmany, P.;
Theunissen, C. Synthesis 2017, 49, 3183. (d) Wang, X.-N.; Yeom,
H.-S.; Fang, L.-C.; He, S.; Ma, Z.-X.; Kedrowski, B. L.; Hsung, R. P.
Acc. Chem. Res. 2014, 47, 560. (e) DeKorver, K. A.; Li, H.; Lohse, A.
G.; Hayashi, R.; Lu, Z.; Zhang, Y.; Hsung, R. P. Chem. Rev. 2010,
110, 5064.
(8) For early examples see: (a) Davies, P. W.; Cremonesi, A.; Martin,
N. Chem. Commun. 2011, 47, 379. (b) Li, C.; Zhang, L. Org. Lett.
2011, 13, 1738. (c) Davies, P. W.; Cremonesi, A.; Dumitrescu, L.
Angew. Chem. Int. Ed. 2011, 50, 8931. (d) Kramer, S.;
Odabachian, Y.; Overgaard, J.; Rottländer, M.; Gagosz, F.;
Skrydstrup, T. Angew. Chem. Int. Ed. 2011, 50, 5090.
(e) Mukherjee, A.; Dateer, R. B.; Chaudhuri, R.; Bhunia, S.; Karad,
S. N.; Liu, R.-S. J. Am. Chem. Soc. 2011, 133, 15372. (f) Dateer, R.
B.; Shaibu, B. S.; Liu, R.-S. Angew. Chem. Int. Ed. 2012, 51, 113.
(g) Rettenmeier, E.; Schuster, A. M.; Rudolph, M.; Rominger, F.;
(13) To complement the 2-thiaspiro[4.5]decane motif 5 accessed
from ynamides 2, their alkyne precursor was tested under the
conditions previously developed for the reaction of terminal
alkynes (see ref. 5), providing access to a 2-thiaspiro[5.5]unde-
can-4-one motif (see SI).
(14) (a) Zheng, Y.; Tice, C. M.; Singh, S. B. Bioorg. Med. Chem. Lett.
2014, 24, 3673. (b) Zheng, Y.-J.; Tice, C. M. Expert Opin. Drug Dis-
covery 2016, 11, 831.
(15) Spagnol, G.; Heck, M.-P.; Nolan, S. P.; Mioskowski, C. Org. Lett.
2002, 4, 1767.
(16) Attempts to extrude sulfur dioxide from 13 were unsuccessful
with no conversion even in diphenyl ether at 280 °C.
© 2021. Thieme. All rights reserved. Synlett 2021, 32, A–D